Results 1 to 10 of about 119,783 (316)

Recent Developments In Brain-Targeted Drug Delivery Systems via Intranasal Route [PDF]

open access: yesFarmacja Polska, 2023
Diseases of the human nervous system such as neurological infections, Parkinson's, Alzheimer's, and other neurodegenerative diseases are severe pathological diseases and become a public health problem.
Ahmad Ainurofiq   +5 more
doaj   +1 more source

Evaluation of the Pharmacokinetics of Intranasal Drug Delivery for Targeting Cervical Lymph Nodes in Rats

open access: yesPharmaceutics, 2021
A well-developed lymphatic network is located under the nasal mucosa, and a few drugs that permeate the nasal mucosa are absorbed into the lymphatic capillaries. Lymph from the nasal cavity flows to the cervical lymph nodes (CLNs).
Tomoyuki Furubayashi   +4 more
doaj   +1 more source

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

open access: yesPharmaceutics, 2023
Depression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Quercetin (QER) demonstrated antidepressant effects in rats exhibiting anxiety and depressive-like behaviors.
Mohammed H. Elkomy   +10 more
doaj   +1 more source

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies

open access: yesPharmaceutics, 2023
Numerous neurological disorders have a pathophysiology that involves an increase in free radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the brain against oxidative stress-induced neurodegeneration.
Mohammed H. Elkomy   +10 more
doaj   +1 more source

Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin

open access: yesPharmaceutics, 2022
Oxytocin (OT), a mammalian neurohormone associated with social cognition and behavior, can be administered in its synthetic form intranasally (IN) and impact brain chemistry and behavior.
Megan DuBois   +5 more
doaj   +1 more source

Effect of two surfactants on in vitro permeation of butorphanol through horse nasal mucosa

open access: yesUniciencia, 2021
The aim of the present study was to evaluate the effect of two surfactants on in vitro permeation of butorphanol through equine nasal mucosa. Franz diffusion cells and equine nasal mucosa were used. Three formulations were developed based on citric acid,
María Inés Velloso   +2 more
doaj   +1 more source

Lamotrigine-Loaded Poloxamer-Based Thermo-Responsive Sol–Gel: Formulation, In Vitro Assessment, Ex Vivo Permeation, and Toxicology Study

open access: yesGels, 2023
The present study aimed to prepare, characterize, and evaluate a thermo-responsive sol–gel for intranasal delivery of lamotrigine (LTG), which was designed for sustained drug delivery to treat epilepsy.
Maria Riaz   +8 more
doaj   +1 more source

Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability

open access: yesPharmaceuticals, 2023
Psychiatric and neurodegenerative disorders are amongst the most prevalent and debilitating diseases, but current treatments either have low success rates, greatly due to the low permeability of the blood–brain barrier, and/or are connected to severe ...
Patrícia C. Pires   +2 more
doaj   +1 more source

Anti-Inflammatory Drug Repurposing for Intranasal Delivery: Ketoprofen Nanoemulgel Development for the Treatment of Glioma

open access: yesEngineering Proceedings, 2023
The anti-inflammatory drug ketoprofen has shown promising results in the field of drug repurposing for the treatment of brain cancer, but currently developed formulations are for invasive administration (intravenous) and have very limited drug strength ...
Patrícia C. Pires   +3 more
doaj   +1 more source

TLR2 signaling is required for the innate, but not adaptive response to LVS clpB

open access: yesFrontiers in Immunology, 2014
Toll-like receptor 2 (TLR2) is the best characterized pattern-recognition receptor for the highly pathogenic intracellular bacterium, Francisella tularensis.
Lydia Marie Roberts   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy